Aug 19 (Reuters) - Australian biotech giant CSL (CSL.AX), opens new tab said on Tuesday it plans to demerge its influenza vaccine division, CSL Seqirus, into a separately listed company by the end of ...
Oct 30 (Reuters) - Australia's CSL (CSL.AX), opens new tab said on Thursday its vaccine arm, CSL Seqirus and Vaccine Industrial Company, had inked a deal with Saudi Arabia's Health Ministry to ...
CSL is laying off up to 15% of its workforce as the Australian pharma looks to cut R&D costs and spin out its vaccine subsidiary in a wide-ranging restructure. The Melbourne-headquartered company will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results